Foamix Pharmaceuticals Ltd Revenue per Employee (FOMX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Foamix Pharmaceuticals Ltd   (FOMX)
 

Foamix Pharmaceuticals Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Foamix Pharmaceuticals Ltd 's Revenue per employee grew on a trailing twelve month basis to $ 6,515, below the company average.
Within the Consumer Non Cyclical sector Foamix Pharmaceuticals Ltd achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Foamix Pharmaceuticals Ltd has 68 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FOMX Revenue per Employee (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Revenue Change -84.3 % - - -66 % -17.55 %
Sales per Employee (TTM) $ 6,515 17,176 29,897 44,074 52,868
FOMX's Total Ranking # # # # 3743 # 3991
Seq. Revenue Change - - - -64.19 % -0.58 %

FOMX Company Profile >> Back to FOMX Efficiency Comparisons >> Compare FOMX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 84,632 $ 64,838 $ 44,074
(Jun 30 2017)   (Mar 31 2019)



Financial Statements
Foamix Pharmaceuticals Ltd 's Revenue MRQ $ 0 Millions Visit FOMX's Income Statement
Foamix Pharmaceuticals Ltd 's Revenues TTM $ 0 Millions Visit FOMX's aggregate revenue growth
What are FOMX's Sales? Visit FOMX's Sales by Segment




Other Ratios
Foamix Pharmaceuticals Ltd 's Income per Employee
Employees in Legal Cannabis
Legal Cannabis Industry Revenue per Employee Trends and Statistics
Consumer Non Cyclical Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FOMX's Revenue per Employee versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FOMX's Competitors
Revenue per Employee for FOMX's Suppliers
Revenue per Employee for FOMX's Customers

You may also want to know
FOMX's Sales Growth Rates FOMX's Pe Price to earnings ratio FOMX's Receivables Turnover Ratio FOMX's Stock Quote
FOMX's Net Income Growth Rates FOMX's Ps Price to Sales ratio FOMX's Sales per Employee FOMX's Asset Turnover Ratio
FOMX's Net Margin FOMX's Pb Price to Book ratio FOMX's Financial Strength Ratios FOMX's Dividend Payout Ratio
Date modified: 2026-09-18T13:11:04+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2019, within Consumer Non Cyclical Sector Revenue per Employee Revenue 12 months ending Dec 31 2019Number of Employees Dec 31 2019
Dswiss Inc   9,121.97 $ 0.274  Million 30 
Senestech Inc   5,958.33 $ 0.143  Million 24 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.